Non-Invasive Blood Glucose Monitoring Devices Market Booming Worldwide and Advancement Outlook 2026

Non-Invasive Blood Glucose Monitoring
Devices Market Size, Trend, Outlook,
Future Analysis And Synthesis By 2026
Non-invasive blood glucose monitoring devices measures blood glucose levels in patients suffering from
diabetes, without puncturing the skin, or causing pain or trauma. The frequent change in blood glucose
levels in diabetic patients has to be tracked by the glucose monitoring device. Glucose monitoring
devices can be invasive or non-invasive but the non-invasive blood glucose monitoring devices market is
increasing due to the need of an economic, compact, painless and convenience for the patients to use.
Non-invasive glucose monitoring holds great promise for improving diabetes management by providing
better and pain-free blood glucose measurement leading to expansion of non-invasive blood glucose
monitor market in the forecast period.
Ask for In-depth Sample Copy of Research Report @
https://www.coherentmarketinsights.com/insight/request-sample/1480
Non-Invasive Blood Glucose Monitoring Devices Market Driver
The global non-invasive blood glucose monitoring devices market is expected to be boosted by the
increasing diabetes prevalence. According to World Health Organisation (WHO), in 2014, diabetes
mellitus is a worldwide epidemic disease affecting 422 million people and seventh leading cause of death
in US. The glucose concentration of diabetic patients fluctuates significantly throughout the day which
can lead to serious consequences like kidney failure, strokes, heart attacks, high blood pressure,
blindness and coma. These demand the technologically advanced devices for frequent monitoring of
blood glucose levels. Moreover, the invasive techniques of blood glucose monitor are painful and
expensive as compared to non-invasive blood glucose monitoring device, this makes non-invasive blood
glucose monitoring device as the device of choice amongst the patients. Furthermore, the high
percentage of prediabetes patients, a condition were blood glucose levels are high but not sufficient to
detect the diabetes, will also propel the non-invasive blood glucose monitoring device market in the
forecast period. According to NIDDK, in 2015, 33.9% of US adults are estimated to be prediabetes, at
increased risk of developing type 2 diabetes.
Non-Invasive Blood Glucose Monitoring Devices- Regional Analysis
On the basis of region, the global non-invasive blood glucose monitoring device market is
segmented into North America, Latin America, Europe, Asia Pacific, Middle East, and Africa.
North America is expected to be dominant region with respect to non-invasive blood glucose
monitoring device market due to high prevalence of disease in geriatric population which is
25.2 % in US population as per American Diabetes Association of year 2015.
Report includes chapters which deeply display the following deliverable about industry :
• Non-Invasive Blood Glucose Monitoring Devices Market Research Objective and Assumption
• Non-Invasive Blood Glucose Monitoring Devices Market Purview - Report Description,
Executive Summary, and Coherent Opportunity Map (COM)
• Non-Invasive Blood Glucose Monitoring Devices Market Dynamics, Regulations, and Trends
Analysis - Market Dynamics, Regulatory Scenario, Industry Trend, Merger and Acquisitions, New
system Launch/Approvals, Value Chain Analysis, Porter’s Analysis, and PEST Analysis
• Global Non-Invasive Blood Glucose Monitoring Devices Market, By Regions
• Non-Invasive Blood Glucose Monitoring Devices Market Competition by Manufacturers
including Production, Share, Revenue, Average Price, Manufacturing Base Distribution, Sales
Area and Product Type.
• Non-Invasive Blood Glucose Monitoring Devices Market Manufacturers Profiles/Analysis
including Company Basic Information, Manufacturing Base and Its Competitors.
• Non-Invasive Blood Glucose Monitoring Devices Market Manufacturing Cost Analysis including
Key Raw Materials and Key Suppliers of Raw Materials.
• Industrial Chain, Sourcing Strategy and Downstream Buyers including Upstream Raw Materials
Sourcing and Downstream Buyers
• Marketing Strategy Analysis, Distributors/Traders including Marketing Channel, Market
Positioning and Distributors/Traders List.
• Market Effect Factors Analysis including Technology Progress/Risk, Consumer Needs/Customer
Preference Change and Economic/Political Environmental Change.
• Non-Invasive Blood Glucose Monitoring Devices Market Forecast including Production,
Consumption, Import and Export Forecast by Type, Applications and Region.
• Research Findings and Conclusion
Non-Invasive Blood Glucose Monitoring Devices Market - Competitors
The major players for non-invasive blood glucose monitoring device market are Abbott Laboratories, F.
Hoffmann-La Roche Ltd., Integrity Applications, Inc., Bayer Healthcare, Pendragon Medical, Animas
Technologies, Omron and OrSense.
Non-Invasive Blood Glucose Monitoring Devices Market Taxonomy:
By Technology:
• Bio-impedance spectroscopy
• Electromagnetic sensing
• Fluorescence
• Mid-infrared / Near infrared spectroscopy
• Optical coherence tomography
• Optical polarimetry
• Raman spectroscopy
• Reverse iontophoresis
• Ultrasound technology
By Modality:
• Wearable
• Non-wearable / table top
By End Users
• Hospitals & Clinics
• Diagnostic centers
• Homecare setting
Browse Full Report @ https://www.coherentmarketinsights.com/ongoing-insight/noninvasive-blood-glucose-monitoring-devices-market-1480
About Coherent Market Insights
Coherent Market Insights is a prominent market research and consulting firm offering actionready syndicated research reports, custom market analysis, consulting services, and competitive
analysis through various recommendations related to emerging market trends, technologies, and
potential absolute dollar opportunity.
Contact Us
Mr. Shah
Coherent Market Insights
1001 4th Ave, #3200
Seattle, WA 98154
Tel: +1-206-701-6702
Email: sales@coherentmarketinsights.com

The global non-invasive blood glucose monitoring devices market is expected to be boosted by the increasing diabetes prevalence.